Entelexo Biotherapeutics
Entelexo is developing next-generation exosome-based therapeutics to address incurable autoimmune diseases by specifically targeting autoreactive immune cells for effective treatment with mitigated side effects.
Entelexo is developing next-generation exosome-based therapeutics to address incurable autoimmune diseases by specifically targeting autoreactive immune cells for effective treatment with mitigated side effects.